Association between C-Reactive Protein Velocity and Left Ventricular Function in Patients with ST-Elevated Myocardial Infarction.
Ariel BanaiDana LevitSamuel MorganItamar LoewensteinIlan MerdlerAviram HochstadtYishay SzekelyYan TopilskyShmuel BanaiYacov ShachamPublished in: Journal of clinical medicine (2022)
C-reactive protein velocity (CRPv), defined as the change in wide-range CRP concentration divided by time, is an inflammatory biomarker associated with increased morbidity and mortality in patients with ST elevation myocardial infarction (STEMI) treated with primary percutaneous intervention (PCI). However, data regarding CRPv association with echocardiographic parameters assessing left ventricular systolic and diastolic function is lacking. Echocardiographic parameters and CRPv values were analyzed using a cohort of 1059 patients admitted with STEMI and treated with primary PCI. Patients were stratified into tertiles according to their CRPv. A receiver operating characteristic (ROC) curve was used to evaluate CRPv optimal cut-off values for the prediction of severe systolic and diastolic dysfunction. Patients with high CRPv tertiles had lower left ventricular ejection fraction (LVEF) (49% vs. 46% vs. 41%, respectively; p < 0.001). CRPv was found to independently predict LVEF ≤ 35% (HR 1.3 CI 95% 1.21-1.4; p < 0.001) and grade III diastolic dysfunction (HR 1.16 CI 95% 11.02-1.31; p = 0.02). CRPv exhibited a better diagnostic profile for severe systolic dysfunction as compared to CRP (area under the curve 0.734 ± 0.02 vs. 0.608 ± 0.02). In conclusion, For STEMI patients treated with primary PCI, CRPv is a marker of both systolic and diastolic dysfunction. Further larger studies are needed to support this finding.
Keyphrases
- left ventricular
- st elevation myocardial infarction
- percutaneous coronary intervention
- ejection fraction
- acute myocardial infarction
- aortic stenosis
- st segment elevation myocardial infarction
- hypertrophic cardiomyopathy
- cardiac resynchronization therapy
- heart failure
- mitral valve
- coronary artery disease
- left atrial
- oxidative stress
- acute coronary syndrome
- antiplatelet therapy
- coronary artery bypass grafting
- newly diagnosed
- randomized controlled trial
- blood pressure
- end stage renal disease
- chronic kidney disease
- minimally invasive
- atrial fibrillation
- blood flow
- ultrasound guided
- aortic valve
- peritoneal dialysis
- pulmonary hypertension
- drug induced
- coronary artery bypass
- artificial intelligence